Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology
AbstractDue to improved medical care, life expectancy in patients with cystic fibrosis (CF) has veritably improved over the last decades. Importantly, cystic fibrosis related liver disease (CFLD) has become one of the leading causes of morbidity and mortality in CF patients. However, CFLD might be largely underdiagnosed and diagnostic criteria need to be refined. The underlying pathomechanisms are largely unknown, and treatment strategies with proven efficacy are lacking. This review focuses on current invasive and non-invasive diagnostic standards, the current knowledge on the pathophysiology of CFLD, treatment strategies, and possible future developments. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Staufer, K.; Halilbasic, E.; Trauner, M.; Kazemi-Shirazi, L. Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology. Int. J. Mol. Sci. 2014, 15, 13529-13549.
Staufer K, Halilbasic E, Trauner M, Kazemi-Shirazi L. Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology. International Journal of Molecular Sciences. 2014; 15(8):13529-13549.Chicago/Turabian Style
Staufer, Katharina; Halilbasic, Emina; Trauner, Michael; Kazemi-Shirazi, Lili. 2014. "Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology." Int. J. Mol. Sci. 15, no. 8: 13529-13549.